We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





MEDICA 2021 + COMPAMED 2021 Re-Launches In-Person with Innovations Galore for Outpatient and Inpatient Care

By LabMedica International staff writers
Posted on 15 Nov 2021
The world's leading medical trade fair MEDICA and the international trade fair for suppliers to the medical technology industry, COMPAMED, returned to the Düsseldorf exhibition halls in Germany this year from 15 to 18 November 2021 in a presence format.

MEDICA’s 2,900 exhibitors and COMPAMED’s 490 exhibitors arrived from a total of 70 countries at the in-person events. More...
Exhibitors brought their comprehensive portfolios of medical products, devices and instruments, including all the stages in their development, production and distribution processes, to present at MEDICA 2021 and COMPAMED 2021. The themed segments of MEDICA were based around meeting the entire range of needs for inpatient and outpatient care.

The MEDICA segments included: Lab technology & diagnostics, electrotherapy and medical technology, disposables and consumables, information and communication technology (digital health) and physiotherapy and orthopedic technology. The exhibitors at COMPAMED showcased the entire range of products and services that the supplier market provides for medical technology: from individual components and parts, along with innovative materials, to packaging solutions and high-tech processes such as additive manufacturing or complete contract manufacturing.

The significant industry trends and themes, such as an increased demand for digital healthcare solutions or the challenges that service providers face in conjunction with the new EU Medical Device Regulation (MDR), were reflected in the range of products and services that the exhibitors offered and also in the program of the forums and accompanying conferences that were integrated into the trade fairs. In line with the hybrid event concept, the lectures, discussions and award ceremonies for many of these program features could be followed either on-site at the forums’ stages in the trade fair halls or online via a live stream, accessible via the industry portals MEDICA.de and COMPAMED.de, depending upon the preferences of the ticket holder. Further highlights of MEDICA 2021’s program included the 44th German Hospital Conference (as a live stream) and the English language conferences DiMiMED and MEDICA MEDICINE + SPORTS CONFERENCE. These conferences gathered together experts in the fields of military and disaster medicine and in sports medicine and science at the venue in Düsseldorf.

The countries that generally asked for the largest areas before the pandemic were, once again, represented in full force at MEDICA. Italy, South Korea, Turkey, the US and other European nations, such as France, Spain, Great Britain and Poland, were all high on the list behind Germany. After Germany with around 550 exhibitors (MEDICA + COMPAMED), there was a particularly large number of companies from North America. More than 300 exhibitors presented their latest medical technology and medical product solutions to trade visitors from all sectors of the healthcare industry. In addition to the individual exhibitors, North American suppliers also participated in three US and one Canadian pavilion, which were supported by the respective government agencies. Canada's joint stand featured four of the 13 Canadian companies at MEDICA. Of the 223 US companies at MEDICA, 105 exhibited in the two US pavilions in Halls 3 (diagnostic equipment) and 16 (laboratory equipment), while 13 of the 63 US exhibitors at COMPAMED participated in the US pavilion in Hall 14.

"It is pleasant surprise to see such optimism throughout the industry. The broad consensus is that nothing can replace the valuable face-to-face exchanges that international trade shows like MEDICA and COMPAMED provide, said yan Klemm, Senior Business Development Manager at Messe Düsseldorf North America.



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.